been an established lifesaving treatment for patients with severely reduced cardiac function.
Biventricular implantable cardioverter-defibrillator (CRT-D) has
been an established lifesaving treatment for patients with severely reduced cardiac function. 1 Recently, defibrillation threshold (DFT) testing during implantation has been ignored due to its negative effects on cardiac function. However, DFT testing can be helpful for the appropriate management of defibrillators.
A 42-year-old man with a hemodialysis shunt on his left arm was referred to our hospital for advanced management of his heart failure.
He presented with NYHA class III heart failure and had a history of ( Figure 2B ). We were lucky to use the DF-1 lead for the RV shock lead, which has three arms to plug to the device: RV-1, SVC coil, and RV coil. Although we did not try to induce VT/VF again, we believe that the undersensing of VT/VF does not happen again under this situation because the LV signal was excellent during VF and the DFT of a long duration VF is higher than that of a short duration VF.
2-4
Implantable cardioverter-defibrillators (ICDs) or CRT-Ds utilize RV electrogram to detect VT or VF. The special feature to sense LV electrogram during VT/VF helped us to understand the rare phenomenon; "dissociated activation between the ventricles" in this case. Fortunately, we performed DFT testing on this case. DFT testing had been a routine practice during implantation a decade ago. However, the concern that shock itself deteriorates a patients' prognosis arose. 5 Recently, the prospective trial, "SIMPLE trial," has revealed that the implantation of the devices without DFT testing does not increase the mortality of the patients, 6 which suggested that DFT testing can be omitted safely. However, we still had a good reason to perform DFT testing on this case because the device was implanted on the right side and the patient was taking amiodarone, which might elevate DFT. easily because we found it before closing the wound. Dissociated activation during VT between the ventricles is a rare phenomenon and difficult to be found. As far as we know, this is the first report clearly showing the proof of the dissociation. We tried to duplicate this phenomenon later on the next day under transient intravenous anesthesia, but we could not.
The phenomenon seemed to be situation dependent.
In this case, we could not obtain the safety margin of DFT; 10 J.
Maximum shock of 35 J successfully terminated VF, however, 25 J shock failed to terminate left side VF. It took too much time to manage sensing issues and we anticipated the better DFT under the early detection of VF without undersensing. Although changing the position of the lead could be the choice, we did not dare to try another position to minimize the operation time and the surgical stress.
CON CLUS ION
Dissociated activation between the ventricles during VT led to undersensing by a CRT-D. The feature to display LV electrogram during VT/VF was helpful for the correct understanding and the prompt troubleshooting in this case. Although it is a rare phenomenon, we have to reconsider the value of DFT testing.
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